Presentation
17 March 2023 Structure-inherent targeting for biophotonic imaging and targeted therapy
Author Affiliations +
Abstract
While ICG-based NIR imaging has shown great potential in intraoperative surgery, there are two fundamental and unsolved problems facing medical imaging: 1) nonspecific uptake of intravenously administered diagnostic and/or therapeutic agents by normal tissues and organs and 2) incomplete elimination of unbound targeted agents from the body. These problems make image-guided cancer surgery extremely difficult because the background signal is high, and therefore the TBR is low. Designing a targeted contrast agent that shows fast clearance from the background tissues and eventually from the body after complete targeting is the key to the success of image-guided interventions. “Structure-Inherent Targeting” is a strategy that combines tissue-specific targeting components and imaging domain into a single molecule for targeting and imaging specific tissues in real-time, where the compact structural design enables the unbound contrast agent to be easily cleared from the body after targeting.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Hak Soo Choi, Atsushi Yamashita, Seung Hun Park, Kai Bao, Homan Kang, Satoshi Kashiwagi, and Wesley R. Stiles "Structure-inherent targeting for biophotonic imaging and targeted therapy", Proc. SPIE PC12361, Molecular-Guided Surgery: Molecules, Devices, and Applications IX, PC123610E (17 March 2023); https://doi.org/10.1117/12.2653853
Advertisement
Advertisement
KEYWORDS
Tissues

Surgery

Biomedical optics

Image-guided intervention

Near infrared

Cancer

Luminescence

Back to Top